BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  Oculus Innovative Sciences, Inc. to Present at the Rodman & Renshaw 14th Annual Healthcare Conference on September 10th in New York City

  September 5, 2012

   · 

  1 min read
• Policy

  NPS Pharmaceuticals, Inc. Expects to File Natpara™ BLA in Mid-2013

  September 5, 2012

   · 

  1 min read
• Business

  BioMarin Pharmaceutical Inc. Names Jeff Ajer Senior Vice President, Chief Commercial Officer

  September 5, 2012

   · 

  1 min read
• Drug Development

  Alvine Pharmaceuticals, Inc. ALV003 Receives Fast Track Designation From the FDA for the Potential Treatment of Celiac Disease

  September 5, 2012

   · 

  1 min read
• Genetown

  Coronado Biosciences Granted First U.S. Patent Covering CNDO-109

  September 5, 2012

   · 

  1 min read
• Business

  Drug Development Company Invion Formed Following Completion of CBio Limited M&A Transaction

  September 5, 2012

   · 

  4 min read
• Business

  BioMotiv Secures $21 Million in Initial Funding

  September 5, 2012

   · 

  2 min read
• Business

  Peregrine Pharmaceuticals, Inc. to Report First Quarter Fiscal Year 2013 Financial Results Before Market on September 10, 2012

  September 5, 2012

   · 

  1 min read
• Pharm Country

  Johnson & Johnson Notify of 8.8% Shareholding in Galapagos NV

  September 5, 2012

   · 

  2 min read
• Business

  Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces at-the-Market Equity Offering

  September 5, 2012

   · 

  3 min read